Gayatri BioOrganics Limited reported a net loss of ₹10.17 lakh for the quarter ended June 30, 2026, narrowing significantly from the ₹26.29 lakh loss recorded in the same period of FY25. Revenue from operations for Q1FY26 was ₹233.66 lakh. Alongside the financial results, the Board of Directors approved a proposal to change the company’s name to Ananth BioOrganics Limited or similar variants, subject to regulatory approvals. Additionally, Sreedhara Reddy Kanaparthi was appointed as Chairman and Managing Director effective August 5, 2026, succeeding Venkata Sandeep Kumar Reddy Tikkavarapu, who resigned due to professional responsibilities.

The Board meeting, held on August 4, 2026, in Hyderabad, also reviewed the unaudited financial results and the limited review report by MGR & Co, Chartered Accountants. The company announced its 35th Annual General Meeting (AGM) scheduled for September 23, 2026, to be conducted via video conference or other audio-visual means (OAVM). The Board further approved the adoption of new Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act, 2013, pending member approval.

Financial Performance

The company’s total income for the quarter was ₹233.66 lakh, driven entirely by revenue from operations. Total expenses amounted to ₹243.84 lakh, comprising ₹215.45 lakh for purchase of stock-in-trade, ₹15.60 lakh in other expenses, ₹10.68 lakh in finance costs, and ₹2.11 lakh in employee benefits expenses.

For the full year ended March 31, 2026, the company reported a net loss of ₹111.18 lakh on total expenses of ₹111.18 lakh. The paid-up equity share capital remains at ₹7,878.81 lakh. The financial statements were prepared on a going concern basis, supported by a comfort letter from the promoters regarding future business continuity.

Leadership Transition

Venkata Sandeep Kumar Reddy Tikkavarapu resigned as Chairman and Non-Executive Director effective August 5, 2026. He holds 1,70,06,802 shares in the company. Sreedhara Reddy Kanaparthi, previously the Whole-time Director, has been designated as Chairman and Managing Director for a three-year term, subject to member approval. Kanaparthi brings over two decades of experience in leveraging technology for human welfare and holds an MBA from 1999–2001. He confirmed no relationships with other directors and is not debarred by SEBI or any other authority.

What the Numbers Show

The reduction in quarterly net loss from ₹26.29 lakh in Q1FY25 to ₹10.17 lakh in Q1FY26 indicates improved operational efficiency despite continued losses. Total expenses in Q1FY26 were ₹243.84 lakh against revenue of ₹233.66 lakh, suggesting that while the company remains unprofitable, the gap between income and expenditure has narrowed considerably compared to the prior year period where expenses were lower but revenue data was not disclosed in the comparative column. The consistent negative net worth of ₹3,700.49 lakh at the end of FY26 highlights ongoing capital challenges, necessitating the promoter support cited in the going concern note.

gayatri bioorganics has closed its trading window for securities effective from July 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ending June 30, 2026. The closure is mandated by the company's code of conduct for prevention of insider trading, adopted under the SEBI (Prohibition of Insider Trading) Regulations, 2015. This restriction applies to all designated persons, their immediate relatives, and connected persons covered under the code.

The Board of Directors will meet to consider and approve the unaudited financial results for the quarter ending June 30, 2026. A separate intimation regarding the notice of this board meeting will be sent to the stock exchange. Designated persons have been instructed not to trade in the company's securities during the period of closure.

The disclosure was submitted to BSE Limited by Sreedhara Reddy Kanaparthi, Whole-time Director of Gayatri BioOrganics Limited. The company's registered office is located in Hyderabad, Telangana.